Skip to content

UK healthcare workers need better information and guidance on HIV criminalisation

Continuing cotrimoxazole in children on ART reduces the risk of hospitalisation

Mutsa Bwakura-Dangarembizi presenting at CROI 2013.

Black gay men run higher risk of HIV infection despite fewer partners

Hyman Scott, University of California, San Francisco, presenting at CROI 2013.

New NNRTI MK-1439 shows promise in early clinical trial

Matt Anderson at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Dual CCR5/CCR2 inhibitor cenicriviroc has anti-inflammatory as well as anti-HIV effect

Joseph Gathe, Therapeutic Concepts, Houston, Texas © Liz Highleyman / hivandhepatitis.com

Small risk of neurological birth defects due to efavirenz confirmed in French cohort

Jeanne Sibiude of Louis Mourier Hospital, France, presenting at CROI 2013.

HIV treatment for children is safe and highly effective without laboratory monitoring in large African trial

Adeodata Kekitiinwa presenting at CROI 2013.

French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection

Isabelle Poizot-Martin and Laurent Cotte at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Participation in community groups increases uptake of HIV testing services in Zimbabwe